ES482549A0 - Un metodo para la preparacion de una composicion de virus herpes - Google Patents

Un metodo para la preparacion de una composicion de virus herpes

Info

Publication number
ES482549A0
ES482549A0 ES482549A ES482549A ES482549A0 ES 482549 A0 ES482549 A0 ES 482549A0 ES 482549 A ES482549 A ES 482549A ES 482549 A ES482549 A ES 482549A ES 482549 A0 ES482549 A0 ES 482549A0
Authority
ES
Spain
Prior art keywords
preparation
herpes virus
virus composition
vaccine
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES482549A
Other languages
English (en)
Other versions
ES8107300A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES482549A0 publication Critical patent/ES482549A0/es
Publication of ES8107300A1 publication Critical patent/ES8107300A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
ES482549A 1978-07-21 1979-07-17 Un metodo para la preparacion de una composicion de virus herpes Expired ES8107300A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92706978A 1978-07-21 1978-07-21

Publications (2)

Publication Number Publication Date
ES482549A0 true ES482549A0 (es) 1980-12-16
ES8107300A1 ES8107300A1 (es) 1980-12-16

Family

ID=25454121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482549A Expired ES8107300A1 (es) 1978-07-21 1979-07-17 Un metodo para la preparacion de una composicion de virus herpes

Country Status (12)

Country Link
EP (1) EP0008255B1 (es)
JP (1) JPS5519271A (es)
AT (1) ATE3058T1 (es)
AU (1) AU532186B2 (es)
DE (1) DE2965191D1 (es)
DK (1) DK306379A (es)
ES (1) ES8107300A1 (es)
HU (1) HU182530B (es)
IE (1) IE48379B1 (es)
PL (1) PL217216A1 (es)
PT (1) PT69953A (es)
RO (1) RO76563A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
FR2804026B1 (fr) 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
EP3246400B1 (en) 2012-01-09 2019-10-23 Sanofi Pasteur Biologics, LLC Purification of herpes virus
CA2873775C (en) 2012-05-21 2021-04-20 Sanofi Pasteur Limited Herpesvirus compositions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof

Also Published As

Publication number Publication date
AU532186B2 (en) 1983-09-22
PL217216A1 (es) 1980-12-15
ES8107300A1 (es) 1980-12-16
DK306379A (da) 1980-01-22
JPS6332768B2 (es) 1988-07-01
HU182530B (en) 1984-01-30
ATE3058T1 (de) 1983-04-15
JPS5519271A (en) 1980-02-09
RO76563A2 (ro) 1981-04-30
IE48379B1 (en) 1984-12-26
EP0008255B1 (en) 1983-04-13
PT69953A (en) 1979-08-01
DE2965191D1 (en) 1983-05-19
EP0008255A1 (en) 1980-02-20
AU4882079A (en) 1980-01-24

Similar Documents

Publication Publication Date Title
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
DK1149589T3 (da) Proteinadjuvanser
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
FI923347A0 (fi) Blodfaktorer producerade med rekombinant-dna-teknik och foerfarande foer expression av naemnda blodfaktorer samt i naemnda foerfarande anvaenda rekombinanta kokoppvirus.
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
ES2060740T3 (es) Vacunas de virus vivos para la enfermedad de newcastle.
Ashe et al. Inapparent herpes simplex virus infection in inoculated rabbits
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
ATE18007T1 (de) Hepatitisimpfstoff.
AU6605190A (en) Novel infectious bursal disease virus
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
ATE84722T1 (de) Tollwut-lebendimpfstoff.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
NL300073I1 (nl) Vaccin.
DK569985D0 (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
Dardanoni et al. Vaccination against hepatitis B: Evaluation of the prevaccination markers.
ATE159758T1 (de) Azelluläre impfstoffe
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
ES516673A0 (es) "un metodo para preparar una vacuna para estimular la produccion de anticuerpos contra el virus de la glosopeda".
UA21969A1 (uk) Спосіб виготовлеhhя іhактивоваhої культуральhої вакциhи проти хвороби ауескі
ES2055687T3 (es) Vacuna de virus.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303